Greggi S

No ORCID on file · 5 papers in corpus
other 2025
Endometrioid borderline ovarian tumour: A multicentre analysis from the MITO-14 study
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology ·doi:10.1016/j.ejso.2025.110030

BACKGROUND: The Endometrioid Borderline ovarian tumor (EBOT) is the third most common histological subtype of borderline ovarian tumors. Due to the low incidence of disease, literature is scanty about the prognosis and management of this en…

1999
Positive response to therapy in a patient with a seropositive paraneoplastic cerebellar degeneration and an endometrioid carcinoma of the vesicovaginal septum.
Journal of neurology, neurosurgery, and psychiatry ·doi:10.1136/jnnp.67.3.412
article 1994
Anatomic abnormalities of the retroperitoneum complicating systematic para-aortic and pelvic lymphadenectomy in gynecological oncology.
other 1990
Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy
Oncology ·doi:10.1159/000226836

Fourteen patients with advanced ovarian carcinoma (FIGO stages III-IV) resistant to cisplatin were submitted to an alternating regimen with doxorubicin (A), cyclophosphamide (C), bleomycin (B) and mitomycin C (M). All patients had measurabl…

article 1988
CA 15-3 as a tumor marker in gynecological malignancies
Gynecologic Oncology ·doi:10.1016/0090-8258(88)90032-7

Serum levels of CA 15-3 were measured in 778 samples from 270 patients with benign and malignant gynecological conditions. Malignant tumors were present in 180 patients including 58 cases with cancer of the ovary, 47 of the endometrium, 61 …